フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study PR...
MediPharm Labs Receives Award for CBD Brand of the Year PR Newswire BARRIE, ON, Dec. 8, 2022 For the second...
MediPharm Labs Reports Third Quarter Results PR Newswire TORONTO, Nov. 14, 2022 TORONTO, Nov. 14, 2022...
MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results PR Newswire BARRIE, ON, Nov. 9, 2022...
MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD PR Newswire BARRIE, ON...
MediPharm Labs Reports Second Quarter Results PR Newswire TORONTO, Aug. 15, 2022 TORONTO, Aug. 15, 2022...
MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results PR Newswire BARRIE, ON, Aug. 11, 2022...
MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC PR Newswire BARRIE, ON...
MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous...
MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility PR Newswire BARRIE...
MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders PR Newswire BARRIE, ON...
MediPharm Labs Reports First Quarter Results PR Newswire TORONTO, May 16, 2022 TORONTO, May 16, 2022...
MediPharm Labs Sets Date to Report First Quarter 2022 Financial Results PR Newswire TORONTO, May 12, 2022...
MediPharm Labs Names Experienced Pharma and Med Tech Executive David Pidduck, as CEO PR Newswire BARRIE, ON...
MediPharm Labs Continues to Lead with Innovation - Launches CBG and Water-Soluble Products PR Newswire BARRIE...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約